Deferasirox on COVID-19: safety and efficacy of iron-chelating therapy. A multicentric, randomized, triple blinded study. PPCR [Internet]. 2022 Jan. 10 [cited 2024 Nov. 24];7(4):38-46. Available from: https://journal.ppcr.org/index.php/ppcrjournal/article/view/169